EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of Astragaloside IV Against Cerebral Ischemia–Reperfusion Injury: Inhibiting Neuronal Apoptosis via the CytC/Apaf-1 Mitochondrial Pathway

Tongtong He, Zhe Zhang, Xiaohong Zhou, Ping Gao, Zhenyi Liu, Yanmeng Zhao, Hua Liang, Weijuan Gao, Xiaofei Jin

Pharmaceuticals · 29.03.2026 · 19 (4) · 547

DOI: 10.3390/ph19040547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.03.2026. Verfasst von Tongtong He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luqua…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hebei Province Natural Science Foundation Project, Joint Key Project of Traditional Chinese Medicine, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuronal apoptosis is the core pathological mechanism of cerebral ischemic–reperfusion injury (CIRI); although Astragaloside IV (AS-IV) has demonstrated neuroprotective activity against CIRI, its specific molecular mechanisms underlying the regulation of this apoptosis-related pathway remain to be systematically elucidated.

Methods

We establish an in vivo model of middle cerebral artery occlusion/reperfusion (MCAO/R) in rats and an in vitro model of oxygen–glucose deprivation/reperfusion (OGD/R) in PC12 cells. Six core apoptotic proteins, including CytC, Apaf-1, BAX, Bcl-2, Caspase3, and Caspase9, were detected using neurological function scoring, TTC/HE/Nissl staining, TUNEL staining, Western blot, and immunofluorescence techniques. Molecular docking and molecular dynamics simulation were utilized to analyze the binding affinity between AS-IV and the aforementioned apoptotic proteins.

Results

Molecular docking and dynamics simulation demonstrated AS-IV stably binds six core apoptotic proteins, and comparative analysis with target-specific reference ligands identified Apaf-1 as its primary target with the most favorable binding properties. In rat MCAO/R models, AS-IV alleviated neurological deficits, reduced cerebral infarct volume and improved brain pathological damage; in PC12 cell OGD/R models, it decreased neuronal apoptosis. Western blot and immunofluorescence confirmed AS-IV downregulated pro-apoptotic proteins (cytoplasmic CytC, Apaf-1, BAX, cleaved-Caspase9/3) and upregulated anti-apoptotic Bcl-2.

Conclusions

This study clarifies the anti-apoptotic molecular mechanism of AS-IV, it alleviates CIRI by targeting the CytC/Apaf-1 mitochondrial apoptotic pathway.

Schlagwörter

Stichwörter der Autor:innen

CytC/Apaf-1 pathwayastragaloside IVcerebral ischemic reperfusion injurymolecular dynamics simulationneuron apoptosis

Autor:innen und Institutionen

  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luquan District, Shijiazhuang 050200, China.
  • Traditional Chinese Medicine Program, Graduate School, Juquan Campus, Hebei University of Chinese Medicine, No. 326, Xinshinan Road, Qiaoxi District, Shijiazhuang 050091, China.

Förderung

  • National Natural Science Foundation of China
  • Hebei Province Natural Science Foundation Project
  • Joint Key Project of Traditional Chinese Medicine, Hebei Provincial Natural Science Foundation
  • Hebei Provincial Administration of Traditional Chinese Medicine Scientific Research Program
  • Yanzhao Medical Research Project, Hebei University of Chinese Medicine
  • pecial Project of Basic Scientific Research Business Funds of Provincial Universities of Hebei University of Chinese Medicine
  • National Natural Science Foundation of China https://ror.org/01h0zpd94
  • Yanzhao Medical Research Project, Hebei University of Chinese Medicine https://ror.org/02qxkhm81

Zitieren

APA

He, T., Zhang, Z., Zhou, X., Gao, P., Liu, Z., Zhao, Y., Liang, H., Gao, W., & Jin, X. (2026). Mechanism of Astragaloside IV Against Cerebral Ischemia–Reperfusion Injury: Inhibiting Neuronal Apoptosis via the CytC/Apaf-1 Mitochondrial Pathway. Pharmaceuticals, 19(4), 547. https://doi.org/10.3390/ph19040547

Vancouver

He T, Zhang Z, Zhou X, Gao P, Liu Z, Zhao Y, et al. Mechanism of Astragaloside IV Against Cerebral Ischemia–Reperfusion Injury: Inhibiting Neuronal Apoptosis via the CytC/Apaf-1 Mitochondrial Pathway. Pharmaceuticals. 2026;19(4):547. doi:10.3390/ph19040547

BibTeX
@article{He2026,
  author = {He, Tongtong and Zhang, Zhe and Zhou, Xiaohong and Gao, Ping and Liu, Zhenyi and Zhao, Yanmeng and Liang, Hua and Gao, Weijuan and Jin, Xiaofei},
  title = {Mechanism of Astragaloside IV Against Cerebral Ischemia–Reperfusion Injury: Inhibiting Neuronal Apoptosis via the CytC/Apaf-1 Mitochondrial Pathway},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {4},
  pages = {547},
  doi = {10.3390/ph19040547}
}
Kostenlos starten →